Evotec invests in Exscientia

Evotec AG has made a €15 million equity investment in Exscientia Ltd which is developing artificial intelligence technologies to aid drug discovery. The German company already has a research collaboration with Exscientia dating from 2016.

Full text available to subscribers only. Click here for information on subscribing to MedNous.